Vesilute is a high-purity, research-grade synthetic dipeptide developed for laboratory studies of bladder and urogenital tissue biology, smooth muscle regulation, and gene-level control in target cells.
Molecular Composition and Mechanistic Profile
Vesilute (Glu-Asp, or ED): A two-amino-acid peptide with the sequence glutamic acid-aspartic acid. Molecular weight is approximately 262 Da (formula C9H14N2O7). It was designed as a synthetic analog linked to bladder or urogenital tissue extracts within the Khavinson bioregulator series.
Structural characteristics: The small size supports cell penetration and proposed interactions with nuclear components. Research models suggest it may influence chromatin structure and gene expression related to bladder wall function, smooth muscle activity, and local tissue homeostasis. Effects have been examined in systems involving detrusor regulation, microcirculation, and inflammatory markers in urogenital tissues.
Experimental data from the originating research program indicate associations with normalization of certain bladder function parameters in observational settings, support for cellular repair processes, and modulation of local tissue responses. Independent controlled studies specifically on Vesilute remain limited, with much of the available information derived from the broader bioregulator framework.
Integrated Research Applications
Vesilute is formulated to support focused investigation of short-peptide effects on urogenital pathways. Representative research domains include:
In vitro and tissue models examining bladder smooth muscle contractility, gene expression patterns, and cellular responses under controlled conditions.
Exploratory work on microcirculation, tissue repair signaling, and related regulatory processes in the lower urinary tract.
Using Vesilute as a single, well-characterized entity allows researchers to evaluate tissue-oriented signaling without the variability of complex tissue extracts.
Analytical Validation and Quality Assurance
Commercial research preparations of Vesilute are typically specified at high purity (often ≥98–99%) and characterized by HPLC and mass spectrometry. These methods confirm identity, sequence integrity, and batch consistency for laboratory use.
Storage and Stability Guidelines
Proper storage preserves structural integrity and experimental reproducibility. Typical guidance for lyophilized Vesilute includes:
Room temperature (unopened, lyophilized): Suitable for limited periods when sealed, dry, and protected from light.
Refrigerated storage (2–8 °C): Appropriate for medium-term maintenance of unopened or reconstituted material used over days to weeks.
Frozen storage (≤ −20 °C, preferably lower for long-term): Recommended for extended timelines, with vials kept well sealed to limit moisture and degradation.
Reconstituted solutions are generally stored cold, protected from light, and used within a defined experimental window according to local lab practices to maintain activity and limit contamination risk.
